Highlights
- Coffee consumption may cut risk of death in kidney disease patients
- Close to 2328 patients suffering from the disease were examined
- Coffee is also known as a stimulant
Love coffee? According to a latest study conducted by a team of Portuguese experts, coffee consumption may increase lifespan and cut risk of death in people suffering from chronic kidney disease. People who had the highest intake of coffee had 24 per cent lower risks of dying, while those in the second, third quartile of caffeine consumption had 12 per cent and 22 per cent lower risk.
"These results suggest that advising patients with CKD to drink more caffeine may reduce their mortality. This would represent a simple, clinically beneficial, and inexpensive option," said Miguel Bigotte Vieira from Centro Hospitalar Lisboa Norte, in Portugal.
Close to 2328 patients suffering from chronic kidney disease were examined for the study and it was concluded that the observational study cannot prove that caffeine reduces the risk of death in patients with CKD, but only suggests the possibility of its protective effect.
Coffee is also known as a stimulant and has long been lauded to have metabolism and stamina boosting properties. Coffee also comes packed with antioxidants and may help cut risks of depression and diabetes. In a study published in the American Chemical Society Journal of Natural Products and conducted by a team of researchers from Denmark, scientists have discovered a certain bioactive substance called 'cafestol' that could help delay the onset of Type-2 diabetes and improve cell function and insulin sensitivity. It has often been touted as one of ideal pre-workout drinks. Coffee consumption boosts alertness and helps in focusing, however a person must not have more than 400mg of caffeine in day from all possible sources.
Inputs from IANS